Abstract
Results of an investigation conducted by the authors show that triparanol lowered serum cholesterol significantly and consistently in a large number of patients by inhibiting the synthesis of cholesterol in the liver and in other tissues.The cholesterol-depressant effect of triparanol is independent of other fat partitions. Triparanol appears to be safe for general clinical use; however, 5 to 10 year follow-up studies must be made before its value in arteriosclerotic heart disease can be determined.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
